Abstract: SA-PO326
Enteral Iron Therapy and Renal Autophagy in Juvenile Mice with Adenine-Induced CKD
Session Information
- Mechanisms Associated with Kidney Fibrosis - II
November 04, 2017 | Location: Hall H, Morial Convention Center
Abstract Time: 10:00 AM - 10:00 AM
Category: Chronic Kidney Disease (Non-Dialysis)
- 308 CKD: Mechanisms of Tubulointerstitial Fibrosis
Authors
- Akchurin, Oleh M., Weill Cornell Medical College, NEW YORK, New York, United States
- Patino, Edwin A, Weill Cornell Medical College, NEW YORK, New York, United States
- Bhatia, Divya, Weill Cornell Medical College, NEW YORK, New York, United States
- Dalal, Vidhi, NYP Cornell, Cornell, New York, United States
- Angara, Sureshbabu, Weill Cornell Medicine, New York City, New York, United States
- Rivella, Stefano, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- Choi, Mary E., Weill Cornell Medical College, NEW YORK, New York, United States
Background
Autophagy has been implicated in the pathophysiology of chronic renal injury and fibrosis. Iron therapy is common in patients with chronic kidney disease (CKD) and non-hematologic effects of iron therapy in CKD are of great interest. Iron-induced oxidative stress can damage cellular proteins and organells, which then need to be recycled by autophagy. However, the effect of iron on renal autophagy has not been elucidated.
Methods
Autophagy proteins Beclin 1 and LC3b were evaluated by western blot in the whole kidney lysates of juvenile C57Bl/6 male mice fed the following four diets from age 3 to 11 weeks:
(1) physiologic diet,
(2) 0.2% adenine diet (CKD),
(3) 0.5% carbonyl iron diet (iron therapy),
(4) 0.2% adenine + 0.5% carbonyl iron diet.
Mice were euthanized after 8 weeks of experimental diet.
Data were analyzed with ANOVA followed by Tukey post-hoc test.
Results
Adenine-induced CKD, as expected, was characterized by elevated serum hepcidin, low serum iron, and low hemoglobin. Iron therapy normalized serum iron and improved anemia in mice with CKD, while further elevating serum hepcidin. Iron therapy led to elevated non-heme iron content in the kidneys of mice with and without CKD. mRNA expression of iron exporter ferroportin was induced by high iron diet in control mice but not in mice with CKD, while kidney ferroportin protein expression was reduced in CKD, irrespective of iron therapy. Iron therapy led to higher expression of autophagy proteins Beclin 1 and LC3b in the kidneys of mice with CKD, as compared to mice with CKD not treated with iron. In contrast, expression of NCOA4, a marker of ferritinophagy, was reduced in mice with CKD, without significant influence of systemic iron status.
Conclusion
To our knowledge, this is the first study that demonstrated induction of renal autophagy by iron therapy in CKD. This effect was not specific to ferritinophagy, as ferritin cargo receptor NCOA4, which mediates its autophagy, was not induced by iron therapy in this model. In our ongoing experiments, we are evaluating mechanistic relationship between iron-mediated autophagy and renal fibrosis in CKD.
Funding
- NIDDK Support